SMT-NK Inj.
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SMT-NK Inj., covering 2022-09-27 to 2022-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2, Phase 3]